GleamWall
中文EN

GWLL GOLDENWELL BIOTECH, INC.

Food and Kindred Products · OTC · SEC CIK 1800373 · Fiscal year ends 12/31

Financial factors as of 2024-12-31 (2024Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY-94.1%
TTM net income YoY-12.4%
TTM EPS YoY—
Revenue 3-yr CAGR-79.9%
Net income 3-yr CAGR—

Margins

Gross margin50.4%
Operating margin-88,556.1%
Net margin-94,542.4%
FCF margin—
EBITDA margin—

Returns

ROE-710.0%
ROA-58.1%
ROIC (approx.)-125.7%
Asset turnover0.00x

Leverage & solvency

Liabilities / assets121.1%
Debt / equity—
Current ratio—
Interest coverage-14.65x

Cash quality & payout

Operating cash flow / net income0.89x
Accruals ratio-6.5%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q42025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q42024-12-31
Income statement
Revenue$0$0$0$55$0$0$0$0
Cost of revenue$0$0$0$43$0$0$0$0
Gross profit$0$0$0$12$0$0$0$0
SG&A expense$29,440$34,776$31,335$22,907$25,795$28,200$36,436$25,352
Operating income-$29,440-$34,776-$31,335-$22,895-$25,795-$28,200-$36,436-$25,352
Interest expense——$2,100$2,100$2,100$2,100$2,100$2,100
Pretax income——————-$34,377—
Income tax$0$0$0$0$0$0$0$0
Net income-$31,540-$36,876-$17,606-$199,740-$27,895-$30,300-$38,536-$27,452
EPS (diluted)—0.000.000.00——0.000.00
Weighted avg. shares (diluted)99.00M99.00M99.00M—99.00M99.00M99.00M—
Banking
Noninterest expense——————$2,100—
Balance sheet
Cash & equivalents$788$11,143$13,414$26,775$45,622$76,507$17,127$49,404
Inventory—$0$0$174,745$174,788$174,788$174,788$174,788
Total assets$14,538$28,978$18,754$36,120$233,760$267,315$191,915$224,192
Current liabilities$100,000$100,000$100,000$101,860$101,860$109,620—$1,860
Long-term debt——————$176,085$173,985
Total debt——————$176,085$173,985
Total liabilities$444,273$427,173$380,073$424,833$377,733$383,393$277,693$271,433
Shareholders' equity-$429,735-$398,195-$361,319-$343,713-$143,974-$116,078-$85,778-$47,241
Net debt——————$158,958$124,581
Shares outstanding99.00M99.00M99.00M99.00M99.00M99.00M99.00M99.00M
Cash flow statement
Operating cash flow-$25,355-$47,271-$13,361-$18,848-$30,885$59,380-$32,276-$19,051
Financing cash flow$15,000$45,000$0$0$0$0$0$63,700

Free plan shows the latest 8 periods; Pro shows all 29 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.